Final Surprise Billing Regulations Cut Insurer Control—Sort Of
It remains far from clear whether the new surprise billing rule goes far enough to fix the problem of insurers having too much power in disputes.
It remains far from clear whether the new surprise billing rule goes far enough to fix the problem of insurers having too much power in disputes.
Revised final rule essentially disarms the threat of insurers having the advantage in out-of-network price disputes.
The process is now slightly less rigged in insurers’ favor.
The VALID Act for FDA regulation of laboratory developed tests is working its way through the final stages of the legislative process, but not everyone is loving it.
The way the No Surprises Act is implemented would essentially allow private health plans to set out-of-network rates in billing disputes.